These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12383044)

  • 1. Absence of interaction of fondaparinux sodium with digoxin in healthy volunteers.
    Mant T; Fournié P; Ollier C; Donat F; Necciari J
    Clin Pharmacokinet; 2002; 41 Suppl 2():39-45. PubMed ID: 12383044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers.
    Ollier C; Faaij RA; Santoni A; Duvauchelle T; van Haard PM; Schoemaker RC; Cohen AF; de Greef R; Burggraaf J
    Clin Pharmacokinet; 2002; 41 Suppl 2():31-7. PubMed ID: 12383043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of fondaparinux sodium in healthy volunteers.
    Donat F; Duret JP; Santoni A; Cariou R; Necciari J; Magnani H; de Greef R
    Clin Pharmacokinet; 2002; 41 Suppl 2():1-9. PubMed ID: 12383039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers.
    Dockens RC; Greene DS; Barbhaiya RH
    J Clin Pharmacol; 1996 Feb; 36(2):160-7. PubMed ID: 8852392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of an effect of a single-dose deferasirox on the steady-state pharmacokinetics of digoxin.
    Sechaud R; Robeva A; Belleli R; Balez S
    Int J Clin Pharmacol Ther; 2008 Oct; 46(10):519-26. PubMed ID: 18826866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilomilast: pharmacokinetic and pharmacodynamic interactions with digoxin.
    Zussman BD; Kelly J; Murdoch RD; Clark DJ; Mbchb ; Schubert C; Collie H
    Clin Ther; 2001 Jun; 23(6):921-31. PubMed ID: 11440291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers.
    Ragueneau I; Poirier JM; Radembino N; Sao AB; Funck-Brentano C; Jaillon P
    Br J Clin Pharmacol; 1999 Sep; 48(3):453-6. PubMed ID: 10510161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers.
    Stangier J; Su CA; Hendriks MG; van Lier JJ; Sollie FA; Oosterhuis B; Jonkman JH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1373-9. PubMed ID: 11185636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of coadministration on the pharmacokinetics of azimilide dihydrochloride and digoxin.
    Toothaker RD; Corey AE; Valentine SN; Agnew JR; Parekh N; Moehrke W; Thompson GA; Powell JH
    J Clin Pharmacol; 2005 Jul; 45(7):773-80. PubMed ID: 15951467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of tegaserod (HTF 919) on the pharmacokinetics and pharmacodynamics of digoxin in healthy subjects.
    Zhou H; Horowitz A; Ledford PC; Hubert M; Appel-Dingemanse S; Osborne S; McLeod JF
    J Clin Pharmacol; 2001 Oct; 41(10):1131-9. PubMed ID: 11583482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Darexaban (YM150), an oral direct factor Xa inhibitor, has no effect on the pharmacokinetics of digoxin.
    Kadokura T; Groenendaal D; Heeringa M; Mol R; Verheggen F; Garcia-Hernandez A; Onkels H
    Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):1-9. PubMed ID: 23754514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on the pharmacokinetics of oral contraceptives, warfarin, and digoxin in healthy participants.
    Devineni D; Manitpisitkul P; Vaccaro N; Bernard A; Skee D; Mamidi RN; Tian H; Weiner S; Stieltjes H; Sha S; Rothenberg P
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):41-53. PubMed ID: 25345427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interaction of sparfloxacin and digoxin.
    Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
    Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of mutual pharmacokinetic interaction between cerivastatin, a new HMG-CoA reductase inhibitor, and digoxin in healthy normocholesterolemic volunteers.
    Weber P; Lettieri JT; Kaiser L; Mazzu AL
    Clin Ther; 1999 Sep; 21(9):1563-75. PubMed ID: 10509851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteers.
    Schwartz JI; De Smet M; Larson PJ; Verbesselt R; Ebel DL; Lins R; Lens S; Porras AG; Gertz BJ
    J Clin Pharmacol; 2001 Jan; 41(1):107-12. PubMed ID: 11144988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the steady-state pharmacokinetics of digoxin in healthy adult subjects.
    Liu F; Vessey L; Wenning L; Connolly S; Buckland M; Johnson-Levonas AO; Denker A; Wagner JA; Lai E
    J Clin Pharmacol; 2010 Jul; 50(7):823-8. PubMed ID: 20197486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do therapeutic doses of acarbose alter the pharmacokinetics of digoxin?
    Cohen E; Almog S; Staruvin D; Garty M
    Isr Med Assoc J; 2002 Oct; 4(10):772-5. PubMed ID: 12389338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of erythromycin and clarithromycin on the pharmacokinetics of intravenous digoxin in healthy volunteers.
    Tsutsumi K; Kotegawa T; Kuranari M; Otani Y; Morimoto T; Matsuki S; Nakano S
    J Clin Pharmacol; 2002 Oct; 42(10):1159-64. PubMed ID: 12362931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of zaleplon on digoxin pharmacokinetics and pharmacodynamics.
    Sanchez Garcia P; Paty I; Leister CA; Guerra P; Frías J; García Pérez LE; Darwish M
    Am J Health Syst Pharm; 2000 Dec; 57(24):2267-70. PubMed ID: 11146970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of eslicarbazepine acetate on the pharmacokinetics of digoxin in healthy subjects.
    Vaz da Silva M; Costa R; Soares E; Maia J; Falcão A; Almeida L; Soares da Silva P
    Fundam Clin Pharmacol; 2009 Aug; 23(4):509-14. PubMed ID: 19500154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.